137 results
8-K/A
EX-10.1
ln2258m7qvbgrsb
5 May 23
Departure of Directors or Certain Officers
4:52pm
8-K
EX-10.2
1xqhpgi3n2i ikfa
19 Sep 22
Viracta Therapeutics’ Board of Directors appoints Mark Rothera as President and Chief Executive Officer
8:10am
8-K
EX-10.1
8yz6snovtmdqw
19 Sep 22
Viracta Therapeutics’ Board of Directors appoints Mark Rothera as President and Chief Executive Officer
8:10am
8-K
EX-10.1
5cg49j9itz65gm 2e
28 May 21
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-99.2
w0jl1z 97
12 May 21
Viracta Therapeutics Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
5:02pm